PROCEPT BioRobotics (PRCT) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Apr, 2026Voting matters and shareholder proposals
Election of three Class II directors to serve until the 2029 annual meeting and until successors are elected and qualified.
Ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Advisory approval of the compensation of named executive officers.
Board of directors and corporate governance
Board recommends a vote FOR all director nominees, FOR auditor ratification, and FOR executive compensation.
Executive compensation and say-on-pay
Shareholders will vote on a non-binding advisory basis to approve the compensation of named executive officers.
Partial view of Summaries dataset, powered by Quartr API
Latest events from PROCEPT BioRobotics
- Virtual meeting to elect directors, ratify auditor, and approve executive pay, with strong governance focus.PRCT
Proxy filing23 Apr 2026 - Launch teams, inventory optimization, and HYDROS upgrades set the stage for growth in 2024–2026.PRCT
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - Strong growth, margin expansion, and innovation drive leadership in BPH and new cancer markets.PRCT
Investor Day 202626 Feb 2026 - Q4 saw record procedures and 12% revenue growth, with 2026 guidance targeting 27%–33% growth.PRCT
Q4 202526 Feb 2026 - Improved visibility, rising utilization, and new clinical studies drive strong growth and margin expansion.PRCT
2024 Truist Securities MedTech Conference3 Feb 2026 - Q2 revenue up 61% to $53.4M, gross margin at 59%, FY24 guidance raised to $217M.PRCT
Q2 20242 Feb 2026 - FDA clears next-gen AI robotic system, reaffirming 2024 guidance and enabling broad US rollout.PRCT
Status Update1 Feb 2026 - Strong clinical results and expanding adoption drive growth, with new cancer studies underway.PRCT
The 44th Annual William Blair Growth Stock Conference31 Jan 2026 - HYDROS launch brings AI-driven workflow, stable margins, and global expansion focus.PRCT
2024 Wells Fargo Healthcare Conference22 Jan 2026